Identifying Prevalent Cases of Breast Cancer in the French Case-mix Databases
暂无分享,去创建一个
M Colonna | A. Schott | L. Remontet | M. Colonna | B Trombert Paviot | F Gomez | F Olive | S Polazzi | L Remontet | N Bossard | N Mitton | A-M Schott | N. Bossard | S. Polazzi | F. Olive | F. Gomez | N. Mitton | B. Trombert Paviot
[1] C. Colin,et al. Qualité et utilité d'un identifiant patient anonyme et unique pour le chaînage des séjours hospitaliers dans les bases de données médicoéconomiques françaises , 2007 .
[2] A. Schott,et al. Breast cancer incidence using administrative data: correction with sensitivity and specificity. , 2009, Journal of clinical epidemiology.
[3] Y. Ohno,et al. Partial cancer prevalence in Japan up to 2020: estimates based on incidence and survival data from population-based cancer registries. , 2008, Japanese journal of clinical oncology.
[4] G. Launoy,et al. Cancer prevalence in France: time trend, situation in 2002 and extrapolation to 2012. , 2008, European journal of cancer.
[5] A. Mariotto,et al. Estimating the variance of cancer prevalence from population-based registries , 2006, Statistical methods in medical research.
[6] Jean Marie Rodrigues,et al. From DRG databases to an epidemiological observatory for colorectal cancer in a French small area oncology network , 2003, MIE.
[7] G. Hédelin,et al. National cancer prevalence estimation in France , 2000, International journal of cancer.
[8] C. Couchoud,et al. Intérêt de l'utilisation du PMSI pour l'analyse d'activité cancérologique d'une structure de soins multidisciplinaire : l'expérience de la coordination de cancérologie des Hospices Civils de Lyon , 2002 .
[9] R. Écochard,et al. Method of correction to assess the number of hospitalized incident breast cancer cases based on claims databases. , 2002, Journal of clinical epidemiology.
[10] B. Trétarre,et al. [Predictive value and sensibility of hospital discharge system (PMSI) compared to cancer registries for thyroïd cancer (1999-2000)]. , 2006, Revue d'epidemiologie et de sante publique.
[11] R. De Angelis,et al. Estimating the completeness of prevalence based on cancer registry data. , 1997, Statistics in medicine.
[12] Paola Pisani,et al. Estimates of the world‐wide prevalence of cancer for 25 sites in the adult population , 2002, International journal of cancer.
[13] J. Goodwin,et al. An approach to identifying incident breast cancer cases using Medicare claims data. , 2000, Journal of clinical epidemiology.
[14] V. Moreno,et al. A comparative analysis of cancer prevalence in cancer registry areas of France, Italy and Spain. , 2002, Annals of oncology : official journal of the European Society for Medical Oncology.
[15] F. Berrino,et al. Contrasts in cancer prevalence in Connecticut, Iowa, and Utah , 2002, Cancer.
[16] F A Allaert,et al. FOIN: a nominative information occultation function. , 1997, Studies in health technology and informatics.
[17] A. Schott,et al. Is it possible to estimate the incidence of breast cancer from medico-administrative databases? , 2008, European Journal of Epidemiology.
[18] C. Quantin,et al. Estimation de la valeur discriminante des traits d’identification utilisés pour le rapprochement des données d’un patient , 2004 .
[19] J. Peng,et al. Evaluation of an algorithm to identify incident breast cancer cases using DRGs data , 2003, European journal of cancer prevention : the official journal of the European Cancer Prevention Organisation.
[20] Calculating the prevalence of cancer. , 1992, Statistics in medicine.
[21] R. De Angelis,et al. Measuring cancer prevalence in Europe: the EUROPREVAL project. , 2002, Annals of oncology : official journal of the European Society for Medical Oncology.